EXPLORING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early recognition of diseases is vital for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease screening has relied on clinical observations and invasive diagnostic methods. However, these strategies often fail to detect diseases in their preclinical stages, when treatment is significantly effective. Eme